Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR)

Detalles Bibliográficos
Autores principales: Le, Dung T, Crocenzi, Todd S, Urum, Jennifer N, Lutz, Eric R, Laheru, Daniel A, Sugar, Elizabeth A, Vonderheide, Robert H, Fisher, George A, Ko, Andrew H, Murphy, Aimee L, McDougall, Katherine, Ferber, Sandy, Brockstedt, Dirk G, Jaffee, Elizabeth M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645503/
http://dx.doi.org/10.1186/2051-1426-3-S2-P155

Ejemplares similares

Ejemplares similares